scispace - formally typeset
N

Nouri L. Ben Zakour

Researcher at University of Sydney

Publications -  62
Citations -  6047

Nouri L. Ben Zakour is an academic researcher from University of Sydney. The author has contributed to research in topics: Genome & Virulence. The author has an hindex of 27, co-authored 60 publications receiving 4822 citations. Previous affiliations of Nouri L. Ben Zakour include University of Queensland & Institut national de la recherche agronomique.

Papers
More filters
Journal ArticleDOI

BLAST Ring Image Generator (BRIG) : simple prokaryote genome comparisons

TL;DR: BRIG is a cross-platform application that enables the interactive generation of comparative genomic images via a simple graphical-user interface and will perform all required file parsing and BLAST comparisons automatically.
Journal ArticleDOI

Recent human-to-poultry host jump, adaptation, and pandemic spread of Staphylococcus aureus

TL;DR: The evolutionary history of a major new animal pathogen that has undergone rapid avian host adaptation and intercontinental dissemination is determined, providing a new paradigm for the impact of human activities on the emergence of animal pathogens.
Journal ArticleDOI

Population Genetic Structure of the Staphylococcus intermedius Group: Insights into agr Diversification and the Emergence of Methicillin-Resistant Strains

TL;DR: A multilocus sequence phylogenetic analysis of isolates from broad host and geographic origins to investigate inter- and intraspecies diversity found that isolates phenotypically identified as S. intermedius are differentiated into three closely related species, S. pseudintermedius, Staphylococcus pseudintermediatedus, and Staphyllococcus delphini.
Journal ArticleDOI

Safety of bacteriophage therapy in severe Staphylococcus aureus infection

TL;DR: The data indicate that AB-SA01 administered in this way is safe in severe S. aureus infections, including infective endocarditis and septic shock, and the measurements of bacterial and phage kinetics in blood samples suggest that 12 h dosing of 109 plaque-forming units may be a rational basis for further studies.